AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$103,598 | -$120,087 | -$80,565 | -$101,621 |
| Dep. & Amort. | $5,498 | $3,910 | $3,096 | $2,664 |
| Deferred Tax | -$2,158 | -$1,180 | -$88 | $5,856 |
| Stock-Based Comp. | $0 | $34,167 | $17,762 | $32,855 |
| Change in WC | $8,671 | -$1,268 | $2,019 | $6,350 |
| Other Non-Cash | $21,603 | $12,749 | -$1,191 | $5,296 |
| Operating Cash Flow | -$55,060 | -$71,709 | -$58,967 | -$48,600 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,592 | -$3,973 | -$2,492 | -$3,161 |
| Net Acquisitions | $0 | $41 | $0 | $371 |
| Inv. Purchases | $0 | $0 | $0 | -$21,229 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $20,929 |
| Other Inv. Act. | $0 | -$33 | $10 | -$371 |
| Investing Cash Flow | -$1,592 | -$3,932 | -$2,482 | -$3,461 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $61,012 | $42,351 | $110,668 | $47,602 |
| Stock Repurch. | -$11,003 | $0 | -$25,619 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $49,469 | $83,420 | $60,924 | $46,108 |
| Financing Cash Flow | $49,469 | $83,420 | $60,924 | $46,108 |
| Forex Effect | -$198 | -$1,544 | -$2,584 | -$809 |
| Net Chg. in Cash | -$7,381 | $6,235 | -$3,109 | -$6,762 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,251 | $3,016 | $6,125 | $12,887 |
| End Cash | $1,870 | $9,251 | $3,016 | $6,125 |
| Free Cash Flow | -$56,652 | -$75,682 | -$61,459 | -$51,761 |